CYAD Chart
See on advanced chart >
About
Founded in 2007, Celyad Oncology SA is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. The Company is developing a pipeline of allogeneic (off-the-shelf) and...
Read More
- HighlightA biotechnology company focused on chimeric antigen receptor T cell therapies for cancer
- ExchangeNASDAQ
- Listing Date06/19/2015
- Established DateInvalid Date
- Full-time Employees28
- AddressRue Edouard Belin 2 1435 Mont-Saint-Guibert Belgium
- Tel32-10-394100
- Website
- Fiscal Year End Date12/31
- Security TypeAmerican Depositary Receipt (Common Stock)
Industry